SCHEMBL4218152

SCHEMBL4218152

O=C(O)c1ccc(-c2ccccc2)cc1Nc1cnc2ccccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.50
MGAM O43451 1/20 0.47
ACLY P53396 5/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
KDM4E B2RXH2 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 2/20 0.46
GFER P55789 1/20 0.46
NGLY1 Q96IV0 1/20 0.46
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4225801 0.93 PAX8 (0.47) KDRMGAMACLYNPC1RAB9A
SCHEMBL4225807 0.83 KDR (0.41) KDRNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL4210958 0.82 TRPV1 (0.50) KDRMGAMNPC1RAB9AKDM4E
SCHEMBL4222990 0.79 ACLY (0.59) ACLYMAPTGFERNGLY1GRIK1
SCHEMBL4223119 0.79 AKR1C3 (0.60) ACLYMAPTGFERNGLY1GRIK1
SCHEMBL468509 0.78 DHODH (0.65) KDRNPC1RAB9AKDM4ESMN1; SMN2
Trifluoroacetic Acid SCHEMBL4220424 0.77 TRPV1 (0.45) KDRNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL4223666 0.77 SIRT2 (0.61) ACLYMAPTGFERNGLY1GRIK1
SCHEMBL18188074 0.77 KDR (0.40) KDRNPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL4215664 0.76 ACLY (0.52) ACLYMAPTGFERNGLY1GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8327467-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2012-12-11 US disclosed
EP-1860098-B1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO LTD (JP) 2012-11-14 EP disclosed
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-04-23 US disclosed
EP-1860098-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-11-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090105474-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP11, MMP3 KDR 4223/4885MGAM 1620/4885ACLY 430/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.